(Q70014000)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3948297%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

title

In vivo studies with the novel anticancer agent mitozolomide (NSC 353451) on Lewis lung carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3948297%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3948297%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

Maurizio D'Incalci

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3948297%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

author name string

E Erba

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3948297%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

L Morasca

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3948297%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

C Horgan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3948297%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

publication date

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3948297%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

7 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3948297%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3948297%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

page(s)

125-128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3948297%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3948297%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00256161

7 October 2019

exact match

0 references

cites work

Effects of the antitumor agent 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one on the DNA of mouse L1210 cells

1 reference

12 December 2020

DNA cross-linking and monoadduct repair in nitrosourea-treated human tumour cells

1 reference

12 December 2020

Flow-cytometric analysis of DNA distribution after VP16-213 treatment of Lewis lung carcinoma

1 reference

12 December 2020

DNA cross-linking and cytotoxicity in normal and transformed human cells treated in vitro with 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d] -1,2,3,5-tetrazin-4(3H)-one.

1 reference

12 December 2020

Reactions of 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in aqueous solution

1 reference

12 December 2020

Antitumour imidazotetrazines--IV. An investigation into the mechanism of antitumour activity of a novel and potent antitumour agent, mitozolomide (CCRG 81010, M & B 39565; NSC 353451).

1 reference

12 December 2020

Antitumour imidazotetrazines. VII. Quantitative analysis of mitozolomide in biological fluids by high-performance liquid chromatography

1 reference

12 December 2020

Antitumor imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one , a novel broad-spectrum antitumor agent

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00256161

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3948297%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

1 reference